Key result
Pretreatment with molsidomine or the ETA receptor antagonist BQ 610 unmasked the positive inotropic effect of ET-1 by preventing ET-induced myocardial ischemia in open-chest rats.
In vivo, the positive inotropic effect of ET-1 is masked by ETA-mediated coronary vasoconstriction and ischemia, but can be unmasked by pretreatment with molsidomine or an ETA receptor antagonist.
Answers are grounded in this paper and cite their sources.
ET-1 inotropy may be masked in vivo by coronary vasoconstriction; leaves open receptor-specific targeting for cardiac effects.
-In vivo studies could not detect a positive inotropy of endothelin (ET)-1 as described in in vitro experiments. ET-induced direct positive inotropy, which seems to be mediated by ETB receptors, may be antagonized in vivo by an indirect cardiodepressive effect owing to an ET-induced coronary vasoconstriction via ETA receptors. This study compares the effects of a dose of 1 nmol/kg ET-1 alone on myocardial contractility and myocardial energy metabolism with the effects of 1 nmol/kg ET-1 after pretreatment with 5 mg/kg molsidomine or with 100 microg/kg of the ETA receptor antagonist BQ 610. We investigated the effects of ET-1 versus saline controls in open-chest rats. In addition to measurements in the intact circulation, myocardial function was examined by isovolumic registrations independent of peripheral vascular effects. We also studied the effect of ET-1 on myocardial high-energy phosphates. Pretreatment with molsidomine and BQ 610 attenuated the ET-induced reduction of cardiac output (ET-1: -62%; molsidomine+ET-1: -47%; BQ 610+ET-1: -27% different from controls). After a transient initial vasodilation, ET-1 raised total peripheral resistance (ET-1: +190%; molsidomine+ET-1: +171%; BQ 610+ET-1: +89%). BQ 610 was more effective in preventing ET-induced vasoconstriction. The increase of isovolumic peak first derivative of left ventricular pressure (ET-1: -2%; molsidomine+ET-1: +16%; BQ 610+ET-1: +19%) after pretreatment with molsidomine or BQ 610 indicates that these drugs unmask the positive inotropy of ET-1. ET-induced myocardial ischemia was abolished by molsidomine and BQ 610. Pretreatment with molsidomine or blockade of ETA receptors by BQ 610 can unmask the positive inotropy of ET-1 by preventing ET-induced myocardial ischemia. The positive inotropic effect of ET-1 seems to be mediated by ETB receptors.
No takes yet. Share an insight, caveat, or question.
Beyer et al. (1999) studied this question. Endothelin-1 (ET-1) with or without molsidomine or BQ 610 vs. Saline controls was evaluated on Cardiac output, total peripheral resistance, and isovolumic peak first derivative of left ventricular pressure. Pretreatment with molsidomine or the ETA receptor antagonist BQ 610 unmasked the positive inotropic effect of ET-1 by preventing ET-induced myocardial ischemia in open-chest rats.
Synapse has enriched 10 related papers. Consider them for comparative context: